Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of CP-461 in the Treatment of Patients With Advanced Melanoma

NCT00060710 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00060710
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00060710 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of CP-461 in the Treatment of Patients With Advanced Melanoma
Lead sponsor
Astellas Pharma Inc
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2003
Completion date
December 31, 2004
Enrollment
35
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma